SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-287485
Filing Date
2020-11-06
Accepted
2020-11-06 08:36:59
Documents
2
Period of Report
2020-11-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d94683d8k.htm 8-K 19027
2 EX-3.1 d94683dex31.htm EX-3.1 3454
  Complete submission text file 0001193125-20-287485.txt   23695
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 201292533
SIC: 2834 Pharmaceutical Preparations